Bayesian analysis of multicentre trial outcomes

Statistical Methods in Medical Research

Volumn 14, Issue 3, 2005, Pages 249-280

  Lawrence Gould, A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; FAMOTIDINE; FINASTERIDE; PLACEBO;

ANALYSIS OF VARIANCE; BAYES THEOREM; CLINICAL RESEARCH; CLINICAL TRIAL; COMPUTER PROGRAM; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; HEARTBURN; HUMAN; MATHEMATICAL COMPUTING; MONOTHERAPY; PREDICTION; QUANTITATIVE ANALYSIS; RANDOMIZATION; REVIEW; STANDARDIZATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANTACIDS; BAYES THEOREM; DOUBLE-BLIND METHOD; DRUGS, INVESTIGATIONAL; FAMOTIDINE; FINASTERIDE; HEARTBURN; HUMANS; MALE; MULTICENTER STUDIES; OUTCOME ASSESSMENT (HEALTH CARE); PLACEBO EFFECT; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS; UNITED STATES;

EID: 20444387530     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1191/0962280205sm400oa     Document Type: Review

References (45)

1. Cornfield J. A Bayesian test of some classical hypotheses with applications to sequential clinical trials. Journal of the American Statistical Association 1966; 61: 577-94.
2. Cornfield J. The Bayesian outlook and its applications (with discussion). Biometrics 1969; 25: 617-57.
3. Grieve AP. A Bayesian analysis of the two-period crossover design for clinical trials (corr., 42: 459). Biometrics 1985; 41: 979-990.
4. Racine A, Grieve AP, Flühler H. Bayesian methods in practice: Experiences in the pharmaceutical industry. Applied Statistics-Journal of the Royal Statistical Society Series C 1986; 35(2): 93-150.
5. Spiegelhalter DJ, Freedman LS. Bayesian approaches to clinical trials. In Bernardo JM, DeGroot MH, Lindley DV, Smith AFM, eds. Bayesian statistics 3. Oxford: Oxford University Press, 1988: 453-77.
6. Spiegelhalter DJ, Freedman LS, Parmar MKB. Bayesian approaches to randomized trials. In Berry DA, Stangl DK, eds. Bayesian biostatistics. New York: Marcel Dekker, 1996: 67-108.
7. Gilks WR, Clayton DG, Spiegelhalter DJ, Best NG, McNeil AJ, Sharples LD et al. Modelling complexity: Applications of Gibbs sampling in medicine. Journal of the Royal Statistical Society Series B-Methodological 1993; 55: 1-39.
8. Lindley DV, Smith AFM. Bayes estimates for the linear model. Journal of the Royal Statistical Society Series B-Methodological 1972; 34(1): 1-41.
9. Spiegelhalter DJ, Thomas A, Best NG, Gilks WR. WinBugs Version 1.4 User Manual. MRC Biostatistics Unit, Institute of Public Health, University of Cambridge, UK 2002. (ftp.mrc-bsu.cam.ac.uk)
10. Scollnik DPM. Actuarial modeling with MMC and BUGS. North American Actuarial Journal 2001; 5(2): 96-124.
11. Congdon P. Bayesian Statistical modelling. Chichester: John Wiley & Sons, Ltd., 2002.
12. Congdon P. Applied Bayesian modelling. Chichester: John Wiley & Sons, Ltd., 2003.
13. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian data analysis. 2nd edn. New York: CRC Press, 2003.
14. Ibrahim JG, Chen M-H, Sinha D. Bayesian survival analysis. New York: Springer, 2001.
15. Grizzle JE. A note on stratifying versus complete randomization in clinical trials. Controlled Clinical Trials 1982; 3: 365-68.
16. Gould AL. Multi-centre trial analysis revisited. Statistics Medical 1998; 17(15-16): 1779-97.
17. Bryk AS, Raudenbush SW. Hierarchical linear models. Newbury Park, CA: Sage, 1992.
18. Goldstein H. Multilevel statistical models. London: Arnold, 1995.
19. Hedeker D, Gibbons RD. A random-effects ordinal regression model for multilevel analysis. Biometrics 1994; 50(4): 933-44.
20. Leung WC, Harvey I. Is skin ageing in the elderly caused by sun exposure or smoking? British Journal of Dermatology 2002; 147(6):1187-91.
21. Skene AM, Wakefield JC. Hierarchical models for multicentre binary response studies. Statistics in Medicine 1990; 9(8): 919-29.
22. Snijders T, Bosker R. Multilevel analysis. London: Sage, 1999.
23. Aitkin M. A general maximum likelihood analysis of variance components in generalized linear models. Biometrics 1999; 55: 117-28.
24. Carlin BP, Louis TA. Bayes and empirical Bayes methods for data analysis. Boca Raton, FL: Chapman and Hall, 1996.
25. O'Hagan A. Kendall's advanced theory of statistics. Cambridge: Cambridge University Press, 1994.
26. Agresti A. Categorical data analysis, 2nd edn. Hoboken, NJ: John Wiley & Sons, 2002.
27. Barnhart HX, Sampson AR. Overview of multinomial models for ordinal data. Communications in Statistics, Part A (Theory and Methods) 1994; 23(12): 3395-416.
28. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika 1967; 54: 167-79.
29. McCullagh P. Regression models for ordinal data (with discussion). Journal of the Royal Statistical Society Series B-Statistical Methodology 1980; 42: 109-42.
30. Peterson B, Harrell FEJ. Partial proportional odds model for ordinal response variables. Applied Statistics-Journal of the Royal Statistical Society Series C 1990; 39: 205-17.
31. Ananth CV, Kleinbaum DG. Regression models for ordinal responses: A review of methods and applications. International Journal of Epidemiology 1997; 26(6): 1323-33.
32. Lall R, Campbell MJ, Walters SJ, Morgan K. A review of ordinal regression models applied on health-related quality of life assessments. Statistical Methods in Medical Research 2002; 11(1): 49-67.
33. Hedeker D, Gibbons RD. MIXOR: a computer program for mixed-effects ordinal regression analysis. Computer Methods Programs Biomed 1996; 49(2): 157-76.
34. Northeast SAS Users Group Fitting nonlinear mixed models with the new NLMIXED procedure. Washington, DC: Northeast SAS Users Group, 1999.
35. Bender R, Benner A. Calculating ordinal regression models in SAS and S-Plus. Biometrical Journal 2000; 42(6): 677-99.
36. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD et al. The effect of finasteride in men with benign prostatic hyperplasia. New England Journal of Medicine 1992; 327: 1185-91.
37. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit (with discussion). Journal of the Royal Statistical Society Series B-Methodological 2002; 64(4): 583-616.
38. Smith B. BOA (Bayesian Output Analysis) 1.0.1. 2003 (http://www.public-health.uiowa.edu/boa/) accessed March 2005
39. Goldberg KM, Iglewicz B. Bivariate extensions of the boxplot. Technometrics 1992; 34: 307-20.
40. Kass RE, Raftery AE. Bayes factors. Journal of the American Statistical Association 1995; 90: 773-95.
41. McCullagh P, Nelder JA. Generalized linear models, 2nd edn. London: Chapman and Hall, 1989.
42. Hayat M. BUGtoSAS 2002. (http://www.mcw.edu/pcor/bugs) accessed March 2005
43. Gelman A. Parametrization and Bayesian modeling. Journal of the American Statistical Association. 2004; 99: 537-45
44. Gilks WR, Richarson S, Spiegelhalter DJ. Markov Chain Monte Carlo in practice. London, UK: Chapman and Hall/CRC, 1996.
45. Raftery AE, Richarson S. Model selection for generalized linear models via GLIB: Application to nutrition and breast cancer. In Berry DA, Stangl DK, eds. Bayesian biostatistics. New York: Marcel Dekker, 1996: 321-53.